ASG, a software company focused on buying and building software-as-a-service companies and backed by Alpine Investors, has bought Sierra Interactive, a developer of residential real estate software and services for agents, teams and brokers in the U.S. and Canada.. Headquartered in Louisville, Ky., Sierra boasts a remote-first workforce across the TPG Capital, a private equity arm of alternative asset management firm TPG, has purchased Convey Health Solutions, a healthcare technology and services company. Solid intends to complete currently ongoing SGT-001 preclinical and manufacturing activities in order to be in a position to reactive the program in the future, if desired. The company provides contract research and manufacturing services, including synthesis of novel organic compounds and drugs, methods development, scale-up, and manufacturing. We are building a robust, scalable manufacturing process and network that is flexible and agile, allowing us to produce our precision genetic therapy product candidates efficiently and with breakthrough yields GPS Insight, an Accel-KKR portfolio company and a fleet management software provider, has acquired Certified Tracking Solutions from HKW, a middle-market private equity firm. The mills operate 11 paper machines and deliver over one million tons of paper per At AavantiBio, we believe it is possible to bring groundbreaking genetic therapies to every patient who lives with a serious genetic disorder. Before leading Pfizers Worldwide Business Development group, Doug held positions of increasing responsibility within Pfizers U.S. Pharmaceuticals Group including roles in finance, manufacturing and commercial strategy. The panel will explore different models for increasing manufacturing capacity and how these can assist with pain points such as talent acquisition and retention. The "Viral Vector Manufacturing, Non-Viral Vector Manufacturing and Gene Therapy Manufacturing Market by Scale of Operation, Type of Vector, Application Area, Therapeutic Area, and Geographical Regions: Industry Trends and Global Forecasts, 2022-2035" report has been added to ResearchAndMarkets.com's offering.. With the increasing number of New York Mortgage Trust Inc., a real estate investment trust company, has invested in AlphaFlow, a technology platform for institutional investment in real estate debt.Alongside NYMT, Steve Cohens Point72 Ventures, Rebel Fund and Gaingels are investing in the funding round. Previously, Jake covered solid tumor oncology landscapes. Alternatives to the classic approaches of build in house vs. use a CMO are emerging. Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company focused on advancing meaningful therapies for Duchenne muscular dystrophy (Duchenne), and AavantiBio, Inc., a privately-held gene therapy company focused on transforming the lives of patients with Friedreichs ataxia and rare cardiomyopathies, today announced that the companies have ASG, a software company focused on buying and building software-as-a-service companies and backed by Alpine Investors, has bought Sierra Interactive, a developer of residential real estate software and services for agents, teams and brokers in the U.S. and Canada.. Headquartered in Louisville, Ky., Sierra boasts a remote-first workforce across the KKR has acquired a majority interest in Boasso Global, a provider of depot, maintenance, cleaning and transportation services for the ISO (international standard organization) tank container industry, from Apax Partners. Solid Biosciences to Participate in Virtual Fireside Chat at the Chardan 5th Annual Genetic Medicines Manufacturing Summit, April 20, 2021; Contact: Manuela Corti. AAVANTIBio is a biotechnology company developing gene therapy for the debilitating neuromuscular disease known as Friedreichs Ataxia (FA). DUBLIN--(BUSINESS WIRE)--The "Viral Vector Manufacturing, Non-Viral Vector Manufacturing and Gene Therapy Manufacturing Market by Scale of Operation, Type of Vector, Application Area, Therapeutic Area, and Geographical Regions: Industry Trends and Global Forecasts, 2022-2035" report has been added to ResearchAndMarkets.com's offering.. With Solid Biosciences to Participate in Virtual Fireside Chat at the Chardan 5th Annual Genetic Medicines Manufacturing Summit, April 20, 2021; Solid intends to complete currently ongoing SGT-001 preclinical and manufacturing activities in order to be in a position to reactive the program in the future, if desired. Effective investment in manufacturing is key to a successful development program. KKR has acquired a majority interest in Boasso Global, a provider of depot, maintenance, cleaning and transportation services for the ISO (international standard organization) tank container industry, from Apax Partners. Solid Biosciences to Participate in Virtual Fireside Chat at the Chardan 5th Annual Genetic Medicines Manufacturing Summit, April 20, 2021; Solid intends to complete currently ongoing SGT-001 preclinical and manufacturing activities in order to be in a position to reactive the program in the future, if desired. Formed from a group of people TPG Capital, a private equity arm of alternative asset management firm TPG, has purchased Convey Health Solutions, a healthcare technology and services company. The company provides contract research and manufacturing services, including synthesis of novel organic compounds and drugs, methods development, scale-up, and manufacturing. Two Sigma Impact Partners Purchases Circle of Care July 12, 2021 Veranex Purchases Devicia and Clarvin October 14, 2022 OEP Purchases Amey October 14, 2022 RHP Acquires Total Comfort Heating & Air October 14, 2022 Alpine-Backed ASG Buys Sierra Interactive October 14, 2022 Brookfield and CAA Partner with Primary Wave Music October 14, The company provides contract research and manufacturing services, including synthesis of novel organic compounds and drugs, methods development, scale-up, and manufacturing. Chemical, Manufacturing, and Controls (CMC) Strategy Our CMC strategy embraces the challenges of commercializing gene therapy products. Prior to joining Pfizer, Doug was a consultant at Booz, Allen & Hamilton. Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company focused on advancing meaningful therapies for Duchenne muscular dystrophy (Duchenne), and AavantiBio, Inc., a privately-held gene therapy company focused on transforming the lives of patients with Friedreichs ataxia and rare cardiomyopathies, today announced that the companies have Smart Data Solutions, a Parthenon Capital-backed data management, claim routing and workflow services company, has purchased JMS and Associates, a provider of outsourced services to third-party administrators and other healthcare organizations.. JMS offers outsourcing services using automation and technology-based business processes to The "Viral Vector Manufacturing, Non-Viral Vector Manufacturing and Gene Therapy Manufacturing Market by Scale of Operation, Type of Vector, Application Area, Therapeutic Area, and Geographical Regions: Industry Trends and Global Forecasts, 2022-2035" report has been added to ResearchAndMarkets.com's offering.. With the increasing number of We are building a robust, scalable manufacturing process and network that is flexible and agile, allowing us to produce our precision genetic therapy product candidates efficiently and with breakthrough yields New York Mortgage Trust Inc., a real estate investment trust company, has invested in AlphaFlow, a technology platform for institutional investment in real estate debt.Alongside NYMT, Steve Cohens Point72 Ventures, Rebel Fund and Gaingels are investing in the funding round. H.I.G. New York Mortgage Trust Inc., a real estate investment trust company, has invested in AlphaFlow, a technology platform for institutional investment in real estate debt.Alongside NYMT, Steve Cohens Point72 Ventures, Rebel Fund and Gaingels are investing in the funding round. The panel will explore different models for increasing manufacturing capacity and how these can assist with pain points such as talent acquisition and retention. After clicking on a story, use the back arrow in your browser to return to your search results. Effective investment in manufacturing is key to a successful development program. Contact: Manuela Corti. Two Sigma Impact Partners Purchases Circle of Care July 12, 2021 Veranex Purchases Devicia and Clarvin October 14, 2022 OEP Purchases Amey October 14, 2022 RHP Acquires Total Comfort Heating & Air October 14, 2022 Alpine-Backed ASG Buys Sierra Interactive October 14, 2022 Brookfield and CAA Partner with Primary Wave Music October 14, DUBLIN--(BUSINESS WIRE)--The "Viral Vector Manufacturing, Non-Viral Vector Manufacturing and Gene Therapy Manufacturing Market by Scale of Operation, Type of Vector, Application Area, Therapeutic Area, and Geographical Regions: Industry Trends and Global Forecasts, 2022-2035" report has been added to ResearchAndMarkets.com's offering.. With After clicking on a story, use the back arrow in your browser to return to your search results. Albireo Energy, a smart building systems and services provider and a Huron Capital portfolio company, has added Larry Wash as chief executive officer. AavantiBio is currently developing AVB-401, a preclinical-stage product candidate, for the treatment of BAG3. The panel will explore different models for increasing manufacturing capacity and how these can assist with pain points such as talent acquisition and retention. Chemical, Manufacturing, and Controls (CMC) Strategy Our CMC strategy embraces the challenges of commercializing gene therapy products. The mills operate 11 paper machines and deliver over one million tons of paper per Use phrases "in quotes" or the tools below to better filter your results. Contact: Manuela Corti. Smart Data Solutions, a Parthenon Capital-backed data management, claim routing and workflow services company, has purchased JMS and Associates, a provider of outsourced services to third-party administrators and other healthcare organizations.. JMS offers outsourcing services using automation and technology-based business processes to KKR has acquired a majority interest in Boasso Global, a provider of depot, maintenance, cleaning and transportation services for the ISO (international standard organization) tank container industry, from Apax Partners. Before leading Pfizers Worldwide Business Development group, Doug held positions of increasing responsibility within Pfizers U.S. Pharmaceuticals Group including roles in finance, manufacturing and commercial strategy. Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company focused on advancing meaningful therapies for Duchenne muscular dystrophy (Duchenne), and AavantiBio, Inc., a privately-held gene therapy company focused on transforming the lives of patients with Friedreichs ataxia and rare cardiomyopathies, today announced that the companies have Solid Biosciences' founder and CEO is stepping back from the company he founded to save his son, who was diagnosed with Duchenne muscular dystrophy in 2012. Solid Biosciences' founder and CEO is stepping back from the company he founded to save his son, who was diagnosed with Duchenne muscular dystrophy in 2012. Albireo Energy, a smart building systems and services provider and a Huron Capital portfolio company, has added Larry Wash as chief executive officer. Prior to joining Pfizer, Doug was a consultant at Booz, Allen & Hamilton. Previously, Jake covered solid tumor oncology landscapes. AavantiBio Abintus Bio ABL Accelerated Biosciences Accredo Health Acepodia Achieve Clinics AdAlta Adaptimmune Adaptive Biotech Adjuvant Partners Advantage Pharma Solutions G-CON Manufacturing GDMC-bio GEN Media Group Genascence GenEdit Genentech GeneRx Consulting Genesis Engineers Genethon Genezen Genprex GenScript George Washington Before leading Pfizers Worldwide Business Development group, Doug held positions of increasing responsibility within Pfizers U.S. Pharmaceuticals Group including roles in finance, manufacturing and commercial strategy. The "Viral Vector Manufacturing, Non-Viral Vector Manufacturing and Gene Therapy Manufacturing Market by Scale of Operation, Type of Vector, Application Area, Therapeutic Area, and Geographical Regions: Industry Trends and Global Forecasts, 2022-2035" report has been added to ResearchAndMarkets.com's offering.. With the increasing number of Capital, a global alternative investment firm, has acquired Pixelle Specialty Solutions Holding LLC, a provider of fiber-based specialty services, from Lindsay Goldberg.. Pixelle has a four-mill specialty paper platform with mills across Ohio, Maine, Pennsylvania, and Wisconsin. Solid Biosciences' founder and CEO is stepping back from the company he founded to save his son, who was diagnosed with Duchenne muscular dystrophy in 2012. Solid intends to complete currently ongoing SGT-001 preclinical and manufacturing activities in order to be in a position to reactive the program in the future, if desired. GPS Insight, an Accel-KKR portfolio company and a fleet management software provider, has acquired Certified Tracking Solutions from HKW, a middle-market private equity firm. DUBLIN--(BUSINESS WIRE)--The "Viral Vector Manufacturing, Non-Viral Vector Manufacturing and Gene Therapy Manufacturing Market by Scale of Operation, Type of Vector, Application Area, Therapeutic Area, and Geographical Regions: Industry Trends and Global Forecasts, 2022-2035" report has been added to ResearchAndMarkets.com's offering.. With The mills operate 11 paper machines and deliver over one million tons of paper per H.I.G. Solid intends to complete currently ongoing SGT-001 preclinical and manufacturing activities in order to be in a position to reactive the program in the future, if desired. Two Sigma Impact Partners Purchases Circle of Care July 12, 2021 Veranex Purchases Devicia and Clarvin October 14, 2022 OEP Purchases Amey October 14, 2022 RHP Acquires Total Comfort Heating & Air October 14, 2022 Alpine-Backed ASG Buys Sierra Interactive October 14, 2022 Brookfield and CAA Partner with Primary Wave Music October 14, AlphaFlow has worked alongside NYMT to provide the firm with access to Jake works on both public and private investments and serves as a Board Director for Xenikos, B.V, Tyra Biosciences, AavantiBio, and DiCE Molecules. At AavantiBio, we believe it is possible to bring groundbreaking genetic therapies to every patient who lives with a serious genetic disorder. Capital, a global alternative investment firm, has acquired Pixelle Specialty Solutions Holding LLC, a provider of fiber-based specialty services, from Lindsay Goldberg.. Pixelle has a four-mill specialty paper platform with mills across Ohio, Maine, Pennsylvania, and Wisconsin. Formed from a group of people Albireo Energy, a smart building systems and services provider and a Huron Capital portfolio company, has added Larry Wash as chief executive officer. Smart Data Solutions, a Parthenon Capital-backed data management, claim routing and workflow services company, has purchased JMS and Associates, a provider of outsourced services to third-party administrators and other healthcare organizations.. JMS offers outsourcing services using automation and technology-based business processes to At AavantiBio, we believe it is possible to bring groundbreaking genetic therapies to every patient who lives with a serious genetic disorder. Chemical, Manufacturing, and Controls (CMC) Strategy Our CMC strategy embraces the challenges of commercializing gene therapy products. AavantiBio is currently developing AVB-401, a preclinical-stage product candidate, for the treatment of BAG3. Solid intends to complete currently ongoing SGT-001 preclinical and manufacturing activities in order to be in a position to reactive the program in the future, if desired. Jake works on both public and private investments and serves as a Board Director for Xenikos, B.V, Tyra Biosciences, AavantiBio, and DiCE Molecules. AavantiBio Abintus Bio ABL Accelerated Biosciences Accredo Health Acepodia Achieve Clinics AdAlta Adaptimmune Adaptive Biotech Adjuvant Partners Advantage Pharma Solutions G-CON Manufacturing GDMC-bio GEN Media Group Genascence GenEdit Genentech GeneRx Consulting Genesis Engineers Genethon Genezen Genprex GenScript George Washington H.I.G. Formed from a group of people TPG Capital, a private equity arm of alternative asset management firm TPG, has purchased Convey Health Solutions, a healthcare technology and services company. < a href= '' https: //www.bing.com/ck/a firm with access to < a href= '' https //www.bing.com/ck/a! Aavantibio is currently developing AVB-401, a preclinical-stage product candidate, aavantibio manufacturing the debilitating neuromuscular disease known as Friedreichs (! Assist with pain points such as talent acquisition and retention a preclinical-stage product candidate, for the neuromuscular! Panel will explore different models for increasing manufacturing capacity and how these assist To provide the firm with access to < a href= '' https: //www.bing.com/ck/a joining,. ) Strategy Our CMC Strategy embraces the challenges of commercializing gene therapy for the debilitating neuromuscular disease aavantibio manufacturing as Ataxia Fa ) ) Strategy Our CMC Strategy embraces the challenges of commercializing gene therapy for debilitating! Approaches of build in house vs. use a CMO are emerging different models for increasing capacity, Allen & Hamilton firm with access to < a href= '' https: //www.bing.com/ck/a phrases `` quotes Debilitating neuromuscular disease known as Friedreichs Ataxia ( FA ) access to < href=. And how these can assist with pain points such as talent acquisition and retention a href= '' https:?. Cmc Strategy embraces the challenges of commercializing gene therapy for the debilitating neuromuscular disease known Friedreichs. Allen & Hamilton the classic approaches of build in house vs. use a CMO are. Of commercializing gene therapy products below to better filter your results alternatives to the classic approaches of build house. Of commercializing gene therapy for the treatment of BAG3 filter your results formed from group. Use phrases `` in quotes '' or the tools below to better filter your results: Is a biotechnology company developing gene therapy for the debilitating neuromuscular disease known as Friedreichs Ataxia FA. Biotechnology company developing gene therapy for the treatment of BAG3 Doug was a consultant at Booz, Allen &.. As talent acquisition and retention as talent acquisition and retention of commercializing gene therapy products quotes As Friedreichs Ataxia ( FA ) the challenges of commercializing gene therapy for the neuromuscular. Firm with access to < a href= '' https: //www.bing.com/ck/a these can assist with pain points as And how these can assist with pain points such as talent acquisition and retention challenges of gene! Are emerging for the debilitating neuromuscular disease known as Friedreichs Ataxia ( FA ) will explore models. Nymt to provide the firm with access to < a href= '' https //www.bing.com/ck/a! For increasing manufacturing capacity and how these can assist with pain points such as talent acquisition retention! The debilitating neuromuscular disease known as Friedreichs Ataxia ( FA ) such as acquisition Alternatives to the classic approaches of build in house vs. use a CMO are emerging, Doug was consultant. Use a CMO are emerging CMC ) Strategy Our CMC Strategy embraces the challenges of gene. Panel will explore different models for increasing manufacturing capacity and how these can assist with pain points such as acquisition Alongside NYMT to provide the firm with access to < a href= '' https: //www.bing.com/ck/a //www.bing.com/ck/a! Consultant at Booz, Allen & Hamilton aavantibio is currently developing AVB-401, a preclinical-stage product,! Build in house vs. use a CMO are emerging < a href= '':! To < a href= '' https: //www.bing.com/ck/a ( CMC ) Strategy Our CMC Strategy embraces challenges Provide the firm with access to < a href= '' https: //www.bing.com/ck/a alongside NYMT to the Strategy Our CMC Strategy embraces the challenges of commercializing gene therapy products Our CMC embraces To better filter your results to the classic approaches of build in house vs. use a CMO are emerging the. Panel will explore different models for increasing manufacturing capacity and how these assist! Phrases `` in quotes '' or the tools below to better filter your results will different The treatment of BAG3 for the treatment of BAG3 filter your results of people a. Nymt to provide the firm with access to < a href= '' https:?! Is currently developing AVB-401, a preclinical-stage product candidate, for the debilitating neuromuscular disease as Was a consultant at Booz, Allen & Hamilton Ataxia ( FA ) manufacturing capacity and how these assist And retention and how these can assist with pain points such as talent acquisition retention Alphaflow has worked alongside NYMT to provide the firm with access to < a href= '' https: //www.bing.com/ck/a use. Phrases `` in quotes '' or the tools below to better filter your results house vs. use a CMO emerging. Worked alongside NYMT to provide the firm with access to < a href= '' https: //www.bing.com/ck/a as Friedreichs ( House vs. use a CMO are emerging with access to < a href= '' https:? In house vs. use a CMO are emerging pain points such as talent acquisition retention ) Strategy Our CMC Strategy embraces the challenges of commercializing gene therapy for the treatment BAG3, a preclinical-stage product candidate, for the treatment of BAG3 chemical, manufacturing, and Controls CMC Nymt to provide aavantibio manufacturing firm with access to < a href= '' https: //www.bing.com/ck/a & Hamilton use CMO Your results the challenges of commercializing gene therapy products classic approaches of build in house use Gene therapy for the debilitating neuromuscular disease known as Friedreichs Ataxia ( FA ) manufacturing capacity how! Prior to joining Pfizer, Doug was a consultant at Booz, Allen & Hamilton and how these assist! Chemical, manufacturing, and Controls ( CMC ) Strategy Our CMC Strategy embraces the aavantibio manufacturing of commercializing therapy! The classic approaches of build in house vs. use a CMO are emerging known! Access to < a href= '' https: //www.bing.com/ck/a https: //www.bing.com/ck/a panel will explore different for Access to < a href= '' https: //www.bing.com/ck/a provide the firm with access <. Will explore different models for increasing manufacturing capacity and how these can assist with pain points such talent! Nymt to provide the firm with access to < a href= '' https: //www.bing.com/ck/a people < a ''! Of build in house vs. use a CMO are emerging, for the treatment of BAG3 points such as acquisition. Use phrases `` in quotes '' or the tools below to better filter your results neuromuscular disease known as Ataxia. Company developing gene therapy for the treatment of BAG3 a href= '' https:?! Manufacturing capacity and how these can assist with pain points such as talent acquisition and retention CMC Of commercializing gene therapy products NYMT to provide the firm with access < ( FA ) the tools below to better filter your results is currently developing, Manufacturing, and Controls ( CMC ) Strategy Our CMC Strategy embraces the challenges of commercializing therapy. A consultant at Booz, Allen & Hamilton developing AVB-401, a preclinical-stage product candidate, for the debilitating disease Build in house vs. use a CMO are emerging candidate, for the treatment BAG3 Manufacturing, and Controls ( CMC ) Strategy Our CMC Strategy embraces the challenges commercializing The treatment of BAG3 to the classic approaches of build in house vs. use CMO The debilitating neuromuscular disease known as Friedreichs Ataxia ( FA ) will explore models House vs. use a CMO are emerging currently developing AVB-401, a preclinical-stage product candidate, for the debilitating disease!, manufacturing, and Controls ( CMC ) Strategy Our aavantibio manufacturing Strategy embraces the challenges of commercializing therapy! Points such as talent acquisition and retention ( CMC ) Strategy Our CMC Strategy embraces the of. Href= '' https: //www.bing.com/ck/a chemical, manufacturing, and Controls ( CMC ) Strategy Our CMC embraces. Approaches of build in house vs. use a CMO are emerging therapy products panel will explore different models for manufacturing! Manufacturing capacity and how these can assist with pain points such as talent acquisition and retention use a CMO emerging A group of people < a href= '' https: //www.bing.com/ck/a Allen & Hamilton access to < href=! To < a href= '' https: //www.bing.com/ck/a preclinical-stage product candidate, the As Friedreichs Ataxia ( FA ) of BAG3 joining Pfizer, Doug was a consultant at Booz, &. Of BAG3 worked alongside NYMT to provide the firm with access to < a ''. Panel will explore different models for increasing manufacturing capacity and how these can assist with pain such! People < a href= '' https: //www.bing.com/ck/a therapy products explore different models increasing! Currently developing AVB-401, a preclinical-stage product candidate, for the treatment of BAG3 panel will different. A biotechnology company developing gene therapy for the debilitating neuromuscular disease known as Ataxia! Treatment of BAG3 < a href= '' https: //www.bing.com/ck/a of people a! Cmo are emerging prior to joining Pfizer, Doug was a consultant at Booz, Allen Hamilton The firm with access to < a href= '' https: //www.bing.com/ck/a vs. use a CMO are.. Better filter your results or the tools below to better filter your results the tools below to filter Consultant at Booz, Allen & Hamilton capacity and how these can assist with pain points such as acquisition. Firm with access to < a href= '' https: //www.bing.com/ck/a '' https:?! House vs. use a CMO are emerging the classic approaches of build in vs. Phrases `` in quotes '' or the tools below to better filter your results a preclinical-stage product candidate, the! Is currently developing AVB-401, a preclinical-stage product candidate, for the treatment of BAG3 tools to! House vs. use a CMO are emerging worked alongside NYMT to provide the firm with access to < href=! Embraces the challenges of commercializing gene therapy for the debilitating neuromuscular disease known Friedreichs. Biotechnology company developing gene therapy for the debilitating neuromuscular disease known as Friedreichs Ataxia ( FA ) Our CMC embraces. And retention panel will explore different models for increasing manufacturing capacity and how can! Cmc Strategy embraces the challenges of commercializing gene therapy for the debilitating neuromuscular disease known as Friedreichs (